Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Three Arch Partners
company
About
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as
Highlights
Details
- Industries
- Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 1993
- Operating Status
- Active
- Investor Type
- Venture Capital
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Investments
Number of Investments
Number of Lead Investments
6
0
Three Arch Partners has made 6 investments. Their most recent investment was on
Nov 6, 2013, when Ocera Therapeutics raised $28M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 6, 2013
Ocera Therapeutics
|
Post-IPO Equity | $28M | Biopharma | — |
|
Jan 10, 2011
VisionCare Ophthalmic Technologies
|
Series E | $31M | Health Care | — |
|
Apr 2, 2007
Aspen MedTech
|
Series Unknown | $1M | Biotechnology | — |
|
Jan 4, 2005
VisionCare Ophthalmic Technologies
|
Series D | $20M | Health Care | — |
|
Nov 7, 2003
VisionCare Ophthalmic Technologies
|
Series C | $12.40M | Health Care | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
